Facial paralysis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) with oxcarbazepine and reactivation of human herpesvirus 6 (HHV-6)

Int J Dermatol. 2020 Apr;59(4):e114-e115. doi: 10.1111/ijd.14755. Epub 2019 Dec 15.

Authors

Nicolas Kluger^{1

2}, Vincent Descamps², Katriina Lappalainen¹, Reina Roivainen³

Affiliations

¹ Departments of Dermatology, Allergology and Venereology, Helsinki University Hospital, Helsinki, Finland.
² Department of Dermatology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
³ Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Helsinki and Uusimaa Hospital District, Helsinki, Finland.

PMID: 31840232
DOI: 10.1111/ijd.14755

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Adult
Anticonvulsants / adverse effects*
Biopsy
Drug Hypersensitivity Syndrome / complications*
Drug Hypersensitivity Syndrome / diagnosis
Drug Hypersensitivity Syndrome / drug therapy
Drug Hypersensitivity Syndrome / immunology
Epilepsy / drug therapy
Facial Paralysis / blood
Facial Paralysis / diagnosis
Facial Paralysis / drug therapy
Facial Paralysis / etiology*
Glucocorticoids / administration & dosage
Herpesvirus 6, Human / immunology
Herpesvirus 6, Human / isolation & purification
Humans
Male
Oxcarbazepine / adverse effects*
Roseolovirus Infections / blood
Roseolovirus Infections / diagnosis*
Roseolovirus Infections / immunology
Roseolovirus Infections / virology
Skin / immunology
Skin / pathology
Treatment Outcome
Virus Activation / immunology

Substances

Anticonvulsants
Glucocorticoids
Oxcarbazepine